Email Alert | RSS    帮助

中国防痨杂志 ›› 2021, Vol. 43 ›› Issue (3): 248-254.doi: 10.3969/j.issn.1000-6621.2021.03.010

• 论著 • 上一篇    下一篇

结核分枝杆菌中利福平和异烟肼耐药相关基因突变与耐药水平的相关性研究

王希江*, 谭云洪, 贺文从, 欧喜超, 刘东鑫, 赵雁林()   

  1. 830001 乌鲁木齐,新疆维吾尔自治区疾病预防控制中心结核病预防控制中心(王希江);湖南省胸科医院检验科(谭云洪);中国疾病预防控制中心结核病预防控制中心(贺文从、欧喜超、刘东鑫、赵雁林)
  • 收稿日期:2020-10-29 出版日期:2021-03-10 发布日期:2021-03-03
  • 通信作者: 赵雁林 E-mail:zhaoyl@chinacdc.cn
  • 基金资助:
    “十三五”国家科技重大专项(2018ZX10103-001)

The correlation between rifampicin and isoniazid resistance-related gene mutations and resistance level in Mycobacterium tuberculosis

WANG Xi-jiang*, TAN Yun-hong, HE Wen-cong, OU Xi-chao, LIU Dong-xin, ZHAO Yan-lin()   

  1. *Center for Tuberculosis Control and Prevention, Xinjiang Center for Disease Control and Prevention, Urumqi 830049, China
  • Received:2020-10-29 Online:2021-03-10 Published:2021-03-03
  • Contact: ZHAO Yan-lin E-mail:zhaoyl@chinacdc.cn

摘要:

目的 探究结核分枝杆菌中利福平和异烟肼耐药基因突变谱的分布,为研发更为精准的耐药分子诊断技术和临床决策提供依据。方法 收集国家耐药监测点新疆维吾尔自治区柯坪县、岳普湖县和疏勒县193株和湖南省怀化市、永顺县、祁东县、桃江县和耒阳市592株结核分枝杆菌。采用微孔板法测定菌株的最小抑菌浓度(minimum inhibitory concentration,MIC)。根据药物敏感性试验(简称“药敏试验”)结果选取利福平和异烟肼耐药菌株,经CTAB/NaCl法提取核酸后进行全基因组测序(whole genome sequencing,WGS),将所得基因组原始序列过滤后上传至TBprofiler分析工具以确定耐药基因型。结果 785株结核分枝杆菌中,124株(15.80%)为利福平和(或)异烟肼耐药,包括利福平耐药74株,异烟肼耐药111株,耐多药61株(7.77%)。97.22%(70/72)利福平耐药菌株检测出rpoB基因位点突变,其中98.57%(69/70)的突变位于利福平耐药决定区(RRDR),1株检测出RRDR区以外的与利福平耐药相关的罕见突变I491F。利福平耐药突变主要位于rpoB 450、rpoB 445及rpoB 435密码子,占81.43%(57/70),其中rpoB S450L突变出现的频率最高(45.71%,32/70), rpoB 450位点突变对应高浓度利福平耐药(MIC≥16μg/ml),rpoB 452 位点突变主要对应低浓度利福平耐药(MIC=2μg/ml)。93.58%(102/109)的异烟肼耐药菌株存在耐药相关基因突变,85.29%(87/102)的异烟肼突变位于katG 315及fabG1启动子区,katG S315T为最常见的耐药突变(57.84%,59/102),主要对应高浓度异烟肼耐药(MIC≥2μg/ml),其次为fabG1(C15T)(16.67%,17/102),主要对应低浓度异烟肼耐药(MIC=0.25~1.00μg/ml)。结论 不同耐药基因突变导致的结核分枝杆菌耐药水平不同。对于利福平,rpoB 452位点突变对应低浓度耐药,rpoB 445和450位点突变对应高浓度耐药;对于异烟肼,发病fabG1-15突变对应低浓度耐药,katG 315突变对应高浓度耐药。

关键词: 结核,抗多种药物性, 微生物敏感性试验, 基因, 利福平, 异烟肼

Abstract:

Objective To determine the gene mutation profile for rifampicin and isoniazid resistance in Mycobacterium tuberculosis (MTB), and explore its relationship with drug resistance level, provide theoretical basis for the development of molecular drug resistant diagnostic tools to inform clinical decision. Methods MTB strains were collected from Xinjiang Uygur Autonomous Region (Keping, Yuepuhu and Shule county, 193 isolates) and Hunan province (Huaihua, Yongshun, Qidong, Taojiang and Leiyang county, 592 strains). Minimum inhibitory concentration (MIC) method was used to determine rifampicin and isoniazid resistant level. All drug resistant strains were sequenced with whole genome sequencing (WGS), then TB profiler were used for bioinformatics analysis to identify drug resistance mutations. Results Among the 785 MTB strains, 124 (15.80%) were rifampicin/isoniazid resistant isolates, including 74 rifampicin-resistant, 111 isoniazid resistant and 61 multidrug-resistant strains, the multidrug-resistant rate was 7.77%. rpoB gene mutations were detected in 97.22% (70/72) of rifampicin resistance strains, among which 98.75% (69/70) mutations were located in rifampicin resistance determination region (RRDR). The rare mutation associated with rifampicin resistance-I491F (outside the RRDR region) was detected in only one strain. Rifampicin resistance mutations were mainly located in rpoB 450, rpoB 445 and rpoB 435 loci, accounting for 81.43% (57/70), among which rpoB S450L was the most frequent mutation (45.71%, 32/70). rpoB 450 mutation corresponded to high rifampicin resistance (MIC≥16 μg/ml), rpoB 452 mutation mainly corresponded to low rifampicin resistance (MIC=2 μg/ml). For isoniazid resistance strains, 93.58% (102/109) had known drug-resistant related gene mutations, mainly distributed in katG315 and fabG1 promoter region (85.29%, 87/102). KatG S315T was the most common resistance mutation (57.84%, 59/102), mainly corresponding to high isoniazid resistance (MIC≥2 μg/ml), followed by fabG1 (C15T)(16.67%, 17/102) which mainly corresponded to low isoniazid resistance (MIC=0.25-1.00 μg/ml). Conclusion Different drug resistance mutations can cause different degree of drug resistance. For rifampin, the mutation in rpoB 452 corresponded to low level resistant, while the mutations in rpoB 445 and 450 corresponded to high level resistant. For isoniazid, fabG1 C-15T corresponded to low level resistant and the mutation in katG 315 corresponded to high level resistant.

Key words: Tuberculosis,multidrug resistance, Microbial sensitivity tests, Gene, Rifampin, Isoniazid